Yolanda McKinney

National Institutes of Health

Papers

1

Total Citations

147

H-Index

1

About

Yolanda McKinney is a leading figure in molecular imaging, with a focused expertise in the development and clinical translation of novel PET radiotracers for oncology. Her primary research centers on improving the diagnostic accuracy and staging of prostate cancer through advanced imaging techniques. McKinney’s most impactful contribution is her seminal 2013 study on the use of ¹⁸F-FACBC PET/CT for localized prostate cancer detection. This highly cited work (147 citations) was pivotal in demonstrating the radiotracer’s superior ability to characterize intraprostatic tumors, distinguishing malignant tissue from benign prostatic hyperplasia and normal prostate. By directly comparing PET/CT findings with MR imaging and histopathologic analysis, her research provided critical evidence for the potential of FACBC to improve delineation of cancer foci, offering a more precise tool for guiding biopsy and treatment planning. This foundational study has significantly influenced the field of urologic oncology, establishing McKinney as a key contributor to the advancement of non-invasive cancer diagnostics and precision medicine in prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
147
Total Citations
147
Avg Citations/Paper
🏆 Most Cited Paper
Localized Prostate Cancer Detection with<sup>18</sup>F FACBC PET/CT: Comparison with MR Imaging and Histopathologic Analysis
147 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago